医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Taro to Announce First Quarter Results on August 9, 2018

2018年08月03日 AM02:44
このエントリーをはてなブックマークに追加


 

HAWTHORNE, N.Y.

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2018, after the close of market on Thursday, August 9, 2018.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180802005744/en/

CONTACT

Taro Pharmaceutical Industries Ltd.
Mariano A. Balaguer
VP,
CFO
914-345-9001
Mariano.Balaguer@taro.com
or
William
J. Coote

AVP, Business Finance, Treasurer and Investor Relations
914-345-9001
William.Coote@taro.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 武田薬品、ガンマ・デルタ・セラピューティクスの買収により固形がんに対する同種ガンマ・デルタT細胞療法の開発加速を目指す
  • Takeda Applied for Selection of “Prime Market”, Filed Corporate Governance Report With Tokyo Stock Exchange (TSE) in Line With Revised Corporate Governance Code and Published Corporate Governance Related Documents on its Website
  • 武田薬品工業: 新市場区分「プライム市場」の選択申請および改訂コーポレートガバナンス・コードに基づくコーポレート・ガバナンスに関する報告書の提出、ならびにガバナンス関連規程文書の公表について
  • Frazier Healthcare Partners完成8.3亿美元的生命科学公共基金超额认购
  • 武田宣布收购自有股份